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Abstract
Background
Accurate local prevalence of microbial diseases and microbial resistance data are vital for
optimal treatment of patients. However, there are few reports of these data from developing
countries, especially from sub-Saharan Africa. The status of Aga Khan University Hospital
Nairobi as an internationally accredited hospital and a laboratory with an electronic medical
record system has made it possible to analyze local prevalence and antimicrobial suscepti-
bility data and compare it with other published data.
Methods
We have analyzed the spectrum of microbial agents and resistance patterns seen at a 300
bed tertiary private teaching hospital in Kenya using microbial identity and susceptibility
data captured in hospital and laboratory electronic records between 2010 and 2014.
Results
For blood isolates, we used culture collection within the first three days of hospitalization as
a surrogate for community onset, and within that group, Escherichia coli was the most com-
mon, followed by Staphylococcus aureus. In contrast, Candida spp. and Klebsiella pneu-
moniae were the most common hospital onset causes of bloodstream infection.
Antimicrobial resistance rates for the most commonly isolated Gram negative organisms
was higher than many recent reports from Europe and North America. In contrast, Gram
positive resistance rates were quite low, with 94% of S. aureus being susceptible to oxacillin
and only rare isolates of vancomycin-resistant enterococci.
Conclusions
The current report demonstrates high rates of antimicrobial resistance in Gram negative
organisms, even in outpatients with urinary tract infections. On the other hand, rates of
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resistance in Gram positive organisms, notably S. aureus, are remarkably low. A better
understanding of the reasons for these trends may contribute to ongoing efforts to combat
antimicrobial resistance globally.
Introduction
Treatment of suspected bacterial infections is frequently initiated on the basis of clinical pre-
sentation, especially in acutely ill patients. Laboratory tests are performed and therapy is subse-
quently modified based on microbial results and the clinical course. However, accurate initial
empiric therapy depends on understanding of local disease prevalence and susceptibility pat-
terns. Disease prevalence information can identify both similarities and differences in micro-
bial etiologies of clinical syndromes when compared with other regions. The modifications to
the initial empiric therapy depend heavily on timely and accurate microbial data.
When laboratory diagnoses are not available, clinical decision making is based on knowl-
edge or assumptions regarding prevalent pathogens. In sub-Saharan Africa, it is common to
treat acute febrile illness as malaria, even in areas such as Nairobi where there is little or no
malaria transmission. When these assumptions are incorrect, morbidity and mortality result
from missed diagnoses. For example, a study of 251 children with a presumed clinical diagnosis
of severe malaria in Ghana found a high rate of bacteremia (20%) [1]. The mortality in the bac-
teremic group was 39% versus 9.7% for blood culture negative children. This study points out
the compromises to clinical care that can result from lack of accurate and timely laboratory
diagnosis of infectious illnesses. It also demonstrates the potential value of having accurate and
up to-date local information on the spectrum of infectious illnesses. While hospital laboratories
are unable to provide the depth of information that results from community-wide prospective
surveillance, they can point to key trends [2].
There is relatively little published information on levels of antimicrobial resistance within
sub-Saharan Africa. Trends within the region could have varying types of impact on resistance
levels. For example, the availability of broad spectrum antibiotics is limited by cost in a vast
portion of the public sector which could decrease resistance. However, antimicrobial agents are
frequently available without prescriptions and are also used commonly in agriculture for food
animals. In addition, trimethoprim/sulfamethoxazole is widely used for Pneumocystis prophy-
laxis in HIV-infected patients. These practices all have the potential to increase resistance
levels.
In this report, we have studied the microbiology and resistance patterns of infectious dis-
eases seen at AKUHN, illuminating both similarities and differences compared to North Amer-
ican and European data.
Materials and Methods
AKUHN is a 300 bed university hospital in Nairobi Kenya with a range of post-graduate medi-
cal education programs. The patients are primarily from the upper middle and high socioeco-
nomic groups comprised mainly of African Kenyans, Kenyans of Asian descent and a small
Caucasian population- mostly expatriates. The moderate numbers of HIV-infected patients
seen at the hospital reflect the national HIV prevalence of nearly 7%, which is midrange for
sub-Saharan Africa. The hospital has about 50 critical beds, including intensive care unit, coro-
nary care unit, cardiothoracic intensive care unit, neonatal intensive care unit, and high
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dependency units. There is a nine bed outpatient dialysis unit and a cancer center. The hospital
conducts approximately 3600 deliveries in a year.
Microbiology and antigen testing
The hospital laboratory is ISO 15189 accredited by the South Africa national accreditation ser-
vice (SANAS)- the first hospital laboratory in East Africa to achieve this [3]. The microbiology
laboratory performs a range of aerobic bacteriology, mycology and mycobacteriology tests. The
laboratory uses an automated detection system (BD BACTEC™) for blood cultures, and
VITEK1 2 (bioMérieux, France) for microbial identification and susceptibility testing. The
2009 Clinical Laboratory Standards Institute (CLSI) M100-S19 breakpoints were used for
interpretation. When carbapenem resistance was identified by Vitek testing, the results were
routinely confirmed by disk diffusion using an imipenem disk. Supplementary manual meth-
ods are also available, including serotyping to identify Salmonella serovars and streptococcal
species. In cases where automated susceptibilities are not defined, disk diffusion (Oxoid™ disks)
or E-test1 (bioMérieux, France) methods are used. Entero-pathogenic Escherichia coli (EPEC)
testing was performed using commercial antisera obtained from Remel Laboratories (Lenexa,
Kansas, USA; part of Thermo Scientific). Clostridium difficile antigen detection was done using
the Meridian Immunocard (Meridian Bioscience; Inc. USA), which detects toxins A and B. A
series of studies of this test revealed sensitivities ranging from 75% to 98%, while specificities
ranged from 96 to 100% [4].
Data Analysis
Laboratory data have been available since September 2010 on the hospital/laboratory informa-
tion system. The database includes patient location, sample type, and date of hospital admis-
sion (for hospitalized patients). We used this database for microbial prevalence data, excluding
organisms of given sample types that were repeated within a one month period. Antimicrobial
susceptibility data were more complete when obtained directly from the Vitek2 database, and
were available continuously from 2012 through 2014. Within each year, we included only the
first isolation of an organism from a specific sample type. Data are reported by the percent that
are completely susceptible as modified by the Vitek2 algorithm for inferring resistance to spe-
cific antimicrobial agents on the basis of resistance to other drugs in the same class.
All positive cultures from September 2010 through 2014 were extracted from the hospital
information system. Positive cultures were accompanied by relevant demographic data includ-
ing age and sex, inpatient or outpatient and when inpatient, the hospital location of the culture
request, dates of cultures request and hospital admission (for inpatients). When there were
multiple positive cultures from a single source in a single episode of infection, only the first
positive result was included in the analysis. When two cultures with the same organism were
collected more than 30 days apart in the absence of an intervening positive culture, it was con-
sidered as a second episode. Unless stated otherwise, only microbiology samples from the hos-
pital campus were included to avoid referral biases for other sources of samples.
We analyzed the data with the objective of determining which pathogenic organisms were
associated with community onset or with hospital-acquired infection using the collection of
the culture within the first three days of hospitalization versus later as a surrogate marker for
community onset vs. hospital onset. Hospital onset infections are typically defined as those
with symptom onset after at least 48 hours in the hospital. Accurate categorization requires
extensive evaluation of individual patients [5], but for BSI, a culture drawn either two or three
days after admission is highly predictive of hospital acquired infection [6]. We chose a three
day cutoff to allow for a potential one day delay in obtaining the blood culture.
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Ethics Review
The study was reviewed and approved by the clinical research ethics committee of Aga Khan
University Nairobi, Kenya. All individual patient-identifying information was removed prior
to analysis and as such, the study was granted a waiver of requirement for individual consent
by the ethics review committee.
Results
Etiologies of Blood Stream Infections (BSI)
The most common isolate from either group was coagulase negative staphylococci (ConS).
ConS are nonpathogens the majority of time, but can also be pathogenic. When pathogenic, it
is usually in the setting of an intravascular device and supported by at least two positive cul-
tures. Since the clinical information was not available for this analysis, and because most of the
time, just a single blood culture had been obtained, these isolates were excluded from further
analysis. Of note, 77% of the ConS obtained from blood cultures in 2014 were resistant to oxa-
cillin. Likewise, viridans streptococcal blood isolates are nonpathogenic the majority of the
time and were excluded from analysis.
Etiologies of community onset bloodstream infection
Of the organisms causing bacteremia within 72 hours of hospital admission, E. coli was the
most common, followed by S. aureus and S. pneumoniae (together with K. pneumoniae)
respectively (Table 1). It is only when surveying the less common blood isolates that the spec-
trum is significantly different from what is found in developed countries. Notably, Salmonella
species (both typhoidal and non-typhoidal) comprised nearly 6% of community-acquired iso-
lates. We also considered whether the age of our patients was an important contributing factor
in view of the fact that many of the reported series were primarily from children, and the
patient population in the current series was older. Therefore, we compared the ages of patients
with bacteremia caused by E. coli, Klebsiella and Salmonella. The average ages were 57, 40 and
30 years, respectively. When limiting the analysis to patients whose blood cultures were
Table 1. Etiologies of bloodstream infections.
Community Onset Hospital Onset
Organism # % Organism # %
Escherichia coli 124 31% Candida spp. 143 34%
Staphylococcus aureus 65 16% Klebsiella pneumoniae 74 17%
Klebsiella pneumoniae 34 8% Escherichia coli 52 12%
Streptococcus pneumoniae 34 8% Enterococcus spp. 45 11%
Enterococcus spp. 19 5% Staphylococcus aureus 27 6%
Pseudomonas aeruginosa 19 5% Acinetobacter baumannii 21 5%
Streptococcus agalactiae (Gp B strep) 15 4% Enterobacter spp. 20 5%
Candida spp. 14 3% Pseudomonas aeruginosa 16 4%
Cryptococcus neoformans 12 3% Salmonella Typhimurium 6 1%
Salmonella Typhimurium 12 3%
Salmonella Typhi 11 3%
Other community-onset organisms with between 5 and 10 episodes include Streptococcus pyogenes (9), Streptococcus dysgalactiae (6), A. baumannii
(5), Enterobacter spp. (5) and Group D streptococci (5).
doi:10.1371/journal.pone.0147659.t001
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ordered within 3 days of hospitalization, the ages were 59, 46, and 28 years, respectively.
Because of the large number of neonatal bacteremia cases caused by Klebsiella, we also deter-
mined the average ages when excluding patients less than one year of age and found that the
mean ages for E. coli, Klebsiella and Salmonella bacteremia were 60, 56 and 32, respectively,
demonstrating that the age at time of bacteremia for Klebsiella was disproportionately affected
by the neonatal infections. Similarly, Cryptococcus neoformans comprised 3% of community
onset BSI, all or nearly all associated with HIV infection.
Etiologies of hospital acquired bloodstream infection
Candida species were the most common etiologies of hospital onset BSI, with 73% consisting
of non-albicans Candida spp. It is also worth noting that S. aureus was only the fifth most com-
mon cause of hospital onset BSI and that S. aureus was much more likely to be a community-
onset rather than hospital-onset pathogen.
Etiologies of Neonatal BSI
We evaluated neonatal BSI differently than the “all BSI” group, taking into account the under-
standing of the variable definitions of neonatal sepsis. Traditionally, sepsis occurring in the
first month of life has been divided into early (=< 7 days) and late sepsis (8 days to one
month). Alternatively, particularly for premature neonates, it may be divided into sepsis occur-
ring within the first three days or sepsis occurring later than that [7]. Thus, we have divided
our results into sepsis occurring within the first three days, in 4–7 days, or greater than 7 days
(Table 2). S. agalactiae sepsis occurred exclusively within the first 3 days of life while the major-
ity of E. coli, K. pneumoniae and enterococcal cases occurred later than three days. The major-
ity of cases occurring after seven days were premature infants in the newborn intensive care
unit, but some were of community onset in neonates who were admitted to the hospital after
seven days of age. Three S. aureus, two K. pneumoniae, one S. pyogenes, and one S. pneumoniae
episode fell into this class. Enterococci were common in the early and late periods, but how
Table 2. Etiologies of neonatal bloodstream infection.
Organism < = 3d 4-7d >7d Total
Klebsiella pneumoniae 1 8 12 21
Enterococcus spp. 3 2 9 14
Streptococcus agalactiae (Gp B strep) 9 0 0 9
Escherichia coli 1 4 2 7
Enterobacter spp. 1 2 3 6
Staphylococcus aureus 1 0 4 5
Streptococcus Group D 3 0 0 3
Pseudomonas aeruginosa 0 1 2 3
Streptococcus pneumoniae 1 0 1 2
Candida spp. 0 0 2 2
Corynebacterium jeikeium 1 0 0 1
Listeria monocytogenes 1 0 0 1
Acinetobacter baumannii 0 0 1 1
Burkholderia cepacia 0 1 0 1
Serratia marcescens 0 0 1 1
Streptococcus pyogenes 0 0 1 1
doi:10.1371/journal.pone.0147659.t002
Spectrum of Microbial Diseases and Resistance Patterns in Kenya
PLOS ONE | DOI:10.1371/journal.pone.0147659 January 25, 2016 5 / 12
many of these were clinically significant is not known since they are also common as contami-
nants. In contrast to adults, Candida species were not a major cause of BSI.
Urinary Tract Infections in outpatients
The spectrum of isolates was similar to that reported elsewhere in the world, with E. coli as the
leading isolate and Klebsiella spp. a distant second (Table 3).
Stool pathogens
Testing for EPEC was performed only on children under five years of age, so the table is
divided into the two age groups. In children under five, EPEC was the most common pathogen
at 41%, but Salmonella spp. and Shigella spp. were also found commonly. In patients over five,
Salmonella spp. and Shigella spp. were the predominant bacterial pathogens identified in stool
with over 30% for each (Table 3). Salmonella Typhi and Salmonella Paratyphi were rarely iden-
tified from stool cultures, but comprised about half the BSIs due to Salmonella species
(Table 1). The stool samples represented a combination of outpatient and hospitalized patients
with 19% of positive samples obtained from hospitalized patients (27% of positive samples
from children under five and 13% of positive samples for patients over five). The frequency
and severity of C. difficile disease in this region has not been reported. Of 1397 C. difficile
Toxin A and B antigen tests done between 2008 and 2015, 2.6% were positive. This prevalence
rate is low enough that these could all be false positive results. A systematic review found that
the specificity of the test used varied from 94 to 99% in 9 reports, with an average of 97% [4].
Bacterial Resistance
Gram negative organisms. The best window into the community for resistance levels in
certain bacteria is urinary tract cultures from outpatients. Thus, we analyzed the susceptibilities
of urinary pathogens found in specimens from outpatients seen from the years 2012 through
2014 (Table 4). The data are shown separately for each year and overall, there was little change
from year to year. For patients with more than one urine culture demonstrating the same iso-
late, we included only the first within a calendar year. The rate of resistance to a broad range of
antibiotics is striking. The susceptibility in 2014 of only 23% of E. coli and 45% of Klebsiella
spp. to TMP/SMX and the susceptibility of only 22% of E. coli isolates to ampicillin may reflect
the widespread use of these drugs throughout the country. TMP/SMX is routinely recom-
mended for Pneumocystis prophylaxis in HIV-infected patients and ampicillin/amoxicillin is
commonly used for respiratory illness. However, susceptibility rates are also low for other clas-
ses of drugs as well, including 79% and 65% to third generation cephalosporins for E. coli and
Table 3. Etiologies of urinary and gastrointestinal infections.
Urine isolates (2014 only) Stool Isolates (Sept 2010 through 2014)
ORGANISM % Organism < = 5 yrs (n = 356) >5 yrs (n = 455)
Escherichia`coli 76% Salmonella Typhimurium 33% 54%
Klebsiella spp. 11% Shigella species 22% 41%
Staphylococcus saprophyticus 2% EPEC 42% 0%
Enterococcus spp. 2% Campylobacter species 3% 3%
Proteus spp. 2% Salmonella Paratyphi 1% 2%
Morganella morganii 2% Salmonella Typhi 0% 1%
Vibrio cholerae 0% 0%
doi:10.1371/journal.pone.0147659.t003
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Klebsiella, respectively, and 66 and 76% for quinolones. For lower urinary tract infections
caused by E. coli, the best susceptibility among orally administered drugs was nitrofurantoin
(86%).
Gram negative blood isolates were a mixture of community and hospital onset infections.
Thus, the lower susceptibility rates likely reflect the greater number of hospital-acquired iso-
lates. Seventy percent of the E. coli blood isolates were community onset, but even so, the sus-
ceptibility rates in 2014 for cephalosporins and quinolones were substantially lower for blood
than for urine isolates; 55% vs. 74% for third generation cephalosporins and 43% vs. 66% for
quinolones. The difference was more pronounced for Klebsiella spp. for which 69% were hospi-
tal onset. For 2014 Klebsiella spp. isolates, 65% of urine, but only 15% of blood isolates were
susceptible to third generation cephalosporins.
Gram positive organisms. In contrast to the Gram negative organisms, some of the key
Gram positive organisms have much higher susceptibility rates than those reported from
Europe or North America (Table 5). Ninety-four percent of S. aureus isolates were susceptible
to oxacillin, while 84% and 87% were susceptible to tetracycline and erythromycin, respec-
tively. All E. faecalis isolates were susceptible to ampicillin, while 57% and 71% demonstrated
susceptibility to gentamicin and streptomycin for synergy purposes. Vancomycin-resistant E.
Table 4. Susceptibilities of Gram negative organisms: 2012 to 2014.
Organism Source Year Number Amox Amox/Clav TMP/SMX Cipro Cefurox Cefotax Gent Amikacin Mero Ntfn
E. coli Urine 2012 1047 20% 66% 24% 68% 78% 83% 84% 100% 100% 86%
E. coli Urine 2013 903 21% 68% 25% 66% 76% 81% 84% 100% 100% 86%
E. coli Urine 2014 962 22% 68% 23% 66% 74% 79% 85% 100% 100% 86%
K. pneumoniae Urine 2012 135 56% 39% 84% 69% 72% 79% 99% 99%
K. pneumoniae Urine 2013 125 52% 45% 77% 58% 62% 69% 99% 98%
K. pneumoniae Urine 2014 105 53% 45% 76% 62% 65% 74% 100% 99%
P. mirabilis Urine All 81 35% 83% 33% 93% 95% 99% 89% 100% 99%
E. coli Blood 2012 48 10% 50% 15% 33% 42% 46% 79% 98% 100%
E. coli Blood 2013 44 2% 39% 11% 48% 46% 52% 64% 100% 100%
E. coli Blood 2014 47 15% 43% 19% 43% 53% 55% 64% 100% 100%
K. pneumoniae Blood 2012 31 36% 23% 61% 29% 36% 42% 100% 97%
K. pneumoniae Blood 2013 25 32% 32% 64% 32% 36% 48% 88% 92%
K. pneumoniae Blood 2014 27 26% 11% 52% 11% 15% 22% 85% 70%
doi:10.1371/journal.pone.0147659.t004
Table 5. Susceptibilities of Gram positive organisms: 2012 to 2014.
Organism Source Year Number Amox
(BLN)
Pen
HS
Pen HS
or IS
Ntfn Ox Tet Eryt Vanco Linez Gent
syn
Strep
syn
S. saprophyticus Urine 2014 61 49% 100%
E. faecalis Urine 2014 45 98% 100% 98%
S. aureus Blood 2014 18 6% 94% 83% 94% 100% 100%
S. aureus All 2014 271 8% 94% 84% 87% 100% 99%
E. faecalis Blood 2012–
2014
28 100% 100% 96% 57% 71%
S. pneumoniae Blood 2012–
2014
28 46% 100% 82% 93% 100%
S. pneumoniae All 2014 25 24% 84% 68% 64% 100%
CoNS Blood 2014 114 12% 20% 32% 100% 91%
doi:10.1371/journal.pone.0147659.t005
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faecium (VRE) was rarely seen, although the majority of E. faecium isolates were resistant to
ampicillin (data not shown). During the period from 2012 through 2014, there were no signifi-
cant changes in susceptibilities for these organisms.
Discussion
The results presented in this analysis of microbiological laboratory data provide the accuracy
expected of an internationally accredited laboratory with a full range of internal quality as well
as external quality assurance measures. The electronic database has made it possible to do a
comprehensive analysis of the data for over four years (prevalence) and three years
(susceptibilities).
For blood stream pathogens, we used a criterion of including cultures obtained within the
first three days of hospitalization as a surrogate for community onset infections [6]. Since hos-
pital-acquired infections are typically defined as those with symptom onset more than 48
hours after hospitalization, this approach allowed for a one day delay in obtaining the culture.
This approach has the limitation of an occasional misclassification due to community onset
infection with delayed blood culture, as demonstrated by the occasional Salmonella Typhimur-
ium from blood cultures obtained more than three days into hospitalization. In addition, the
finding of occasional cases of candidemia occurring within the first three days points to these
infections as being medical care-related since candidemia is extremely rare in the absence of
predisposing medical interventions. Although the proportion of patients with non-hospital
medical exposure is less than in North America or Europe, there is still a number of patients
with dialysis, chemotherapy, and other types of medical interventions. However, despite these
limitations, the categories give an insight into the predominant organisms causing community
versus hospital onset infections.
For community onset BSI, the top three organisms (Table 1) were similar to findings
reported in several other countries. Three separate studies in Europe that analyzed characteris-
tics of hospital-acquired and community-onset BSI in Austria, Spain and Portugal reported E.
coli, S. pneumoniae, and S. aureus as the predominant organisms in community acquired BSI
[8–10]. This was also reflected in a multicenter cohort study in community hospitals in the
USA where a similar pattern was observed [11]. The major differences from North American
or European series in the current study were in the less frequently seen micro-organisms, such
as the Salmonella species and C. neoformans.
While the Salmonella percentage is higher than in European and American studies, it con-
trasts with the findings of a systematic review in developing countries of South and South East
Asia, in which Salmonella spp. were the most isolated organisms in community acquired BSI
[12]. A systematic review and meta-analysis of 22 studies conducted across Africa on commu-
nity acquired blood stream infections reported S. enterica serotypes as the most and second
most prevalent organisms in adults and children respectively. S. pneumoniae and E. coli were
2nd and 3rd in prevalence among adults, while S. pneumoniae was the most common organism
isolated in children [13]. A portion of the difference of our results from these reports can be
explained by the older population in the current series than in other reports as demonstrated.
The age-related impact on proportion of Salmonella spp. is supported by the younger age in
our population for Salmonella spp. bacteremia than for E. coli or K. pneumoniae. However,
there is also a temporal trend at our institution as demonstrated in a previous publication from
this institution [14] in which Salmonella spp. accounted for 15% of BSIs in HIV-infected
patients and 13% in non-HIV-infected patients (14% of all BSI) from 2003 to 2008. The earlier
series included both community onset and hospital onset BSI, so it contrasts significantly with
the current series in which only about 3% of all BSIs were caused by Salmonella spp. There was
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also a temporal decrease in the portion of Salmonella BSIs due to Salmonella Typhi in that Sal-
monella Typhi caused 59% of Salmonella BSIs in the earlier series and only 38% in the current
series.
Since cryptococcal fungemia is found almost exclusively in advanced HIV, its frequency
dropped with the rollout of antiretroviral therapy in Europe and the US [15–17].
For hospital acquired BSIs, the major differences from other reports are the predominance
of candidemia and the relatively infrequent isolation of S. aureus. In a surveillance of hospital
acquired bacteremia in English hospitals, 26% of the isolates causing hospital-acquired bacter-
emia were S. aureus and 16% CoNS, followed by E. coli and K. pneumoniae [18]. A similar
study in Finnish hospitals showed 65% of the isolates were gram positive led by CoNS, 31%
Gram negative of which majority were E. coli, and 4% were fungal mainly Candida spp. [19].
The finding of S. agalactiae (Group B Strep) as the leading cause of early onset neonatal bac-
teremia is similar to the findings of most western series in which S. agalactiae is the leading
cause of neonatal BSI [20, 21]. E. coli was much less common in the current series as a cause of
early onset BSI, but accounted for a significant number of later onset BSI (five episodes; 11%).
Three of the five occurred within the first seven days of hospitalization. Closer to home, a
study that analyzed bacteremia among children admitted to a rural hospital in Kenya showed
that among infants who were under 60 days old, E. coli and group B streptococci predominated
among a broad range of isolates (14 percent and 11 percent, respectively) [22]. It is important
to note that K. pneumoniae is a major pathogen in community and hospital onset BSIs and in
adults as well as neonates. For neonates, it is the most common hospital onset pathogen and is
also found occasionally as an early onset pathogen.
The susceptibility of E. coli and Klebsiella spp. obtained from blood cultures was much lower
than reported in the West, with susceptibilities of 47% and 24% to third generation cephalo-
sporins, respectively, and 41% and 59% for quinolones (Table 4). In contrast, data from hospi-
tals throughout the United States showed that of the 483 K. pneumoniae isolates implicated in
cases of device-associated BSI, 72.9% were susceptible to 3rd generation cephalosporins [23]
and there was little change in a later survey {Sievert 2013}. A study of Gram negative organisms
from ICUs in the US and Europe showed that about 90% of E. coli in the US and 86% in Europe
were susceptible to third generation cephalosporins and that 85% and 73% of Klebsiella, respec-
tively, were susceptible [24]. Among outpatient urinary isolates of E. coli and Klebsiella from
our institution, only 79% and 65%, respectively, were susceptible to cephalosporins. Thus, the
susceptibility rates among outpatient isolates for third generation cephalosporins in the current
report are actually lower than those of ICU organisms in the US or Europe. The levels of anti-
microbial resistance among Gram negative organisms, particularly community onset K. pneu-
moniae and E. coli are striking and emphasizes a growing appreciation of the urgency of
addressing antimicrobial resistance [25] on a global basis. The level of resistance of K. pneumo-
niae to carbapenems and aminoglycosides is particularly alarming, since the polymyxins and
sometimes tigecycline are currently the only effective alternatives.
In a systematic review of antimicrobial drug resistance among clinically relevant bacterial
isolates in sub-Saharan Africa for community-acquired infections, the median susceptibility to
third-generation cephalosporins ranged between 53.5% and 100% in West Africa, between
84.6% and 94.0% in central South Africa and between 78% and 100% in East Africa [26].
However, some studies from the region have found evidence for high levels of drug resis-
tance among Gram negative rods. In a study of surgical site infections in Tanzania, 61.4% of
the Gram negative rods isolated were multi drug resistant [27]. Another study in Western
Kenya found a majority of the S. Typhi and S. Typhimurium isolates were resistant to at least 4
of the antibiotics used for treatment, however all were susceptible to ciprofloxacin [28]. A com-
bination of factors may be contributing to the high levels of resistance demonstrated in the
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Gram negative organisms in the region. The lack of antibiotic stewardship in health facilities,
misuse of antibiotics by the public and in veterinary practice, weak surveillance of antibiotic
resistance and rudimentary infection control practices play a big role. Although prescriptions
are legally required for antibiotics, the requirement is not enforced, so antibiotic use is common
even among patients who don’t see physicians or other health care providers [29]. Previous
studies within this hospital that determined the genotypes associated with MDR gram nega-
tives found the majority of ESBL producing organisms had blaCTX-M 15. NDM1 was also iso-
lated from seven Klebsiella isolates that were collected as early as 2007 [30].
The low frequency of Gram positive resistance provides a striking contrast to the high rate
of Gram negative resistance. This is most notable for the low rate of MRSA, with 95% of S.
aureus blood isolates and 94% of all S. aureus isolates in the current study being susceptible to
oxacillin, compared with only 43.2% oxacillin susceptibility in a US survey of 1103 S. aureus
isolates [31]. The other remarkable differences included the rarity of VRE in the current report
as well as the lack of S. pneumoniae bloodstream isolates with high level resistance to beta-lac-
tam antibiotics.
An additional contrast with many reports from elsewhere is the infrequent identification of
C. difficile as a pathogen with a prevalence of 2.6% in requested tests. A systematic review
found that the specificity of the test used varied from 94 to 99% in 9 reports, with an average of
97% [4]. Thus, the prevalence rate is low enough that these could all be false positive results. In
addition, no cases of C. difficile colitis severe enough to proceed to colectomy have been identi-
fied (unpublished data). Thus, it remains to be determined whether C. difficile disease is found
locally.
Conclusion
We found similarities as well as notable differences in the patterns of microbial agents and anti-
microbial resistance between our data and what has been reported from Europe and North
America. Gram negative organisms were relatively more common as blood culture isolates. In
addition, the resistance rates of both community onset and hospital onset infections were
higher. Conversely, Gram positive organisms were less resistant, particularly exemplified by
the lowMRSA rates. The determinants for these differences are not obvious and a better under-
standing of the reasons may contribute to ongoing efforts to combat antimicrobial resistance
globally.
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